Daniel Liebler

Daniel Liebler has a diverse work experience in the field of biochemistry and proteomics. Daniel is currently serving as the Vice President of Proteomic Technology at Inotiv since July 2022. Before that, from January 2017 to July 2022, they held the position of President and CEO at Protypia, Inc. Prior to their industry roles, they worked at Vanderbilt University School of Medicine as a Professor of Biochemistry from June 2003 to December 2016. Daniel Liebler started their career in academics as a Professor at the University of Arizona in 1987, where they worked until 2003.

Daniel Liebler completed their education with a Bachelor of Science degree in Chemistry from Villanova University. Daniel then pursued a Doctor of Philosophy degree in Pharmacology from Vanderbilt University School of Medicine.